Rapamycin, But Not Resveratrol or Simvastatin, Extends Life Span of Genetically Heterogeneous Mice-Reference-Cited by-同舟云学术

Rapamycin, But Not Resveratrol or Simvastatin, Extends Life Span of Genetically Heterogeneous Mice

Published:2010-10-25 Issue:2 Volume:66A Page:191-201
ISSN:1758-535X
Container-title:The Journals of Gerontology: Series A
language:en
Short-container-title:

Author:

Miller Richard A.,Harrison David E.,Astle C. M.,Baur Joseph A.,Boyd Angela Rodriguez,de Cabo Rafael,Fernandez Elizabeth,Flurkey Kevin,Javors Martin A.,Nelson James F.,Orihuela Carlos J.,Pletcher Scott,Sharp Zelton Dave,Sinclair David,Starnes Joseph W.,Wilkinson J. Erby,Nadon Nancy L.,Strong Randy

Publisher

Oxford University Press (OUP)

Subject

Geriatrics and Gerontology,Ageing

Link

http://academic.oup.com/biomedgerontology/article-pdf/66A/2/191/16743258/glq178.pdf

Reference51 articles.

1. Nordihydroguaiaretic acid and aspirin increase lifespan of genetically heterogeneous male mice;Strong;Aging Cell,2008

2. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice;Harrison;Nature,2009

3. An aging interventions testing program: study design and interim report;Miller;Aging Cell,2007

4. Statistical methods for testing effects on “maximum lifespan”;Wang;Mech Ageing Dev,2004

5. Below-threshold mortality and its impact on studies in evolutionary ecology;Promislow;J Evol Biol,1999

Cited by 778 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oxidative phosphorylation and fatty acid oxidation in slow-aging mice;Free Radical Biology and Medicine;2024-11

2. Combinatorial lipidomics and proteomics underscore erythrocyte lipid membrane aberrations in the development of adverse cardio-cerebrovascular complications in maintenance hemodialysis patients;Redox Biology;2024-10

3. A single-centre, double-blind, randomized, placebo-controlled, 2-arm study to evaluate the safety and efficacy of once-weekly Sirolimus (Rapamycin) on muscle strength and endurance in older adults following a 13-week exercise program.;2024-08-28

4. Safety and efficacy of rapamycin on healthspan metrics after one year: PEARL Trial Results;2024-08-22

5. Targeting multiple hallmarks of mammalian aging with combinations of interventions;Aging;2024-08-18